Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward

Stefania Chiappini; G Duccio Papanti Pelletier; Rachel Vickers-Smith; John M Corkery; Amira Guirguis; Giovanni Martinotti; Fabrizio Schifano

doi:10.1080/14656566.2023.2271389

Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward

Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1915-1918. doi: 10.1080/14656566.2023.2271389. Epub 2024 Jan 5.

Authors

Stefania Chiappini^{1

2}, G Duccio Papanti Pelletier^{2

3}, Rachel Vickers-Smith⁴, John M Corkery², Amira Guirguis⁵, Giovanni Martinotti^{2

6}, Fabrizio Schifano^{2

6}

Affiliations

¹ Medicine and Surgery Department, UniCamillus - Saint Camillus International University of Health and Medical Sciences, Rome, Italy.
² Psychopharmacology, Drug Misuse, and Novel Psychoactive Substances Research Unit, University of Hertfordshire, College Lane Campus, Hatfield, UK.
³ Cividale Community Mental Health Centre, ASUFC Mental Health Department, Via Carraria 29, Cividale del Friuli (Ud), Italy.
⁴ Department of Epidemiology and Environmental Health, University of Kentucky College of Public Health, Lexington, KY, USA.
⁵ Swansea University Medical School, Institute of Life Science 2, Sketty, UK.
⁶ Department of Neurosciences, Imaging, and Clinical Sciences, University of Chieti-Pescara, Chieti, Italy.

PMID: 37853742
DOI: 10.1080/14656566.2023.2271389

No abstract available

Keywords: New Psychoactive Substances (NPS); binge eating disorder (BED); drug abuse; drug misuse; glucagon-like peptide-1 (GLP-1) agonists; image- and performance- enhancing drugs (IPEDs); pharmacovigilance; semaglutide.

Publication types

Editorial

MeSH terms

Binge-Eating Disorder* / drug therapy
Central Nervous System Agents
Humans
Obesity
Pharmaceutical Preparations

Substances

Central Nervous System Agents
Pharmaceutical Preparations